M&A Deal Summary

Charles River Laboratories International Acquires WIL Research

On January 7, 2016, Charles River Laboratories International acquired life science company WIL Research for 585M USD

Acquisition Highlights
  • This is Charles River Laboratories International’s 14th transaction in the Life Science sector.
  • This is Charles River Laboratories International’s 4th largest (disclosed) transaction.
  • This is Charles River Laboratories International’s 9th transaction in the United States.
  • This is Charles River Laboratories International’s 2nd transaction in Ohio.

M&A Deal Summary
Date 2016-01-07
Target WIL Research
Sector Life Science
Buyer(s) Charles River Laboratories International
Deal Type Add-on Acquisition
Deal Value 585M USD

Target

WIL Research

Ashland, Ohio, United States
website
WIL Research Co., Inc. is a global Contract Research Organization (CRO) that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries, as well as manufacturing support for clinical trials.

Search 193,103 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Charles River Laboratories International

Wilmington, Massachusetts, United States

website

Category Company
Founded 1947
Sector Life Science
Employees18,600
Revenue 3.5B USD (2021)
DESCRIPTION

Charles River Laboratories International is a provider of essential products and contract services to help pharmaceutical and biotechnology companies, government agencies and academic institutions around the globe accelerate their research and drug development efforts. Charles River Laboratories International was incorporated in 1947 and is based in Wilmington, Massachusetts.

DEAL STATS #
Overall 17 of 31
Sector (Life Science) 14 of 28
Type (Add-on Acquisition) 12 of 26
State (Ohio) 2 of 2
Country (United States) 9 of 20
Year (2016) 1 of 3
Size (of disclosed) 4 of 17
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-19 Oncotest

Freiburg, Germany

Oncotest GmbH is a contract research organization (CRO) that provides discovery services for oncology.

Buy €34M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-06-27 Blue Stream Laboratories

Woburn, Massachusetts, United States

Blue Stream Laboratories, Inc. is an analytical contract research organization (CRO) supporting the development of complex biologics and biosimilars. Located in Woburn, Massachusetts, the company is recognized for its expertise in structural and functional protein characterization programs, and the development and validation of assays for current good manufacturing practice (cGMP) lot release and stability programs. Protein characterization is the key element for development and registration of biologic and biosimilar entities.

Buy -
Mergr

Product

Company

Legal